Why Everyone Has A Stake In The Chimerix, Inc. (CMRX) Drug Offered To Dying Boy
3/13/2014 8:16:54 AM
A small biotechnology company agreed yesterday to provide their experimental, antiviral drug for the treatment of a seven-year-old Virginia boy, Joshua Hardy, who is currently suffering from a life-threatening adenovirus infection acquired during his cancer treatment at St. Jude Children’s Hospital.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by